Amgen
AMGN
2,435 hedge funds and large institutions have $98.6B invested in Amgen in 2023 Q1 according to their latest regulatory filings, with 133 funds opening new positions, 1,044 increasing their positions, 889 reducing their positions, and 147 closing their positions.
25% more call options, than puts
Call options by funds: $1.48B | Put options by funds: $1.19B
17% more repeat investments, than reductions
Existing positions increased: 1,044 | Existing positions reduced: 889
0.52% more ownership
Funds ownership: 76.16% → 76.68% (+0.52%)
10% less first-time investments, than exits
New positions opened: 133 | Existing positions closed: 147
3% less funds holding
Funds holding: 2,502 → 2,435 (-67)
9% less capital invested
Capital invested by funds: $108B → $98.6B (-$9.71B)
34% less funds holding in top 10
Funds holding in top 10: 99 → 65 (-34)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS AM
Chicago,
Illinois
|
+$812M |
| 2 |
Envestnet Asset Management
Chicago,
Illinois
|
+$452M |
| 3 |
SP
Sarasin & Partners
London,
United Kingdom
|
+$372M |
| 4 |
Charles Schwab
San Francisco,
California
|
+$362M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$214M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$532M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$458M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$371M |
| 4 |
D.E. Shaw & Co
New York
|
-$229M |
| 5 |
Barclays
London,
United Kingdom
|
-$226M |
AMGN Hedge Fund Activity: Q1 2023 in Review
2,435 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q1 2023, worth a combined $98.6B — down 9% from $108B a quarter earlier.
Sellers outnumbered buyers: 147 funds closed out of AMGN and 133 opened new positions — a net loss of 14 holders — while 889 trimmed existing stakes and 1,044 added.
The largest buyer was UBS AM, opening a new position worth an estimated $812M. The largest seller was JP Morgan Chase, cutting an estimated $532M.
- 2,435 institutional investors held Amgen (AMGN) as of Q1 2023, down from 2,502 in Q4 2022.
- Funds reported $98.6B of Amgen stock for Q1 2023, down 9% quarter-over-quarter.
- 133 funds opened new Amgen positions in Q1 2023 and 147 closed out, a net change of -14 holders.
- The largest Amgen buyer in Q1 2023 was UBS AM, an estimated $812M added.
- The largest Amgen seller in Q1 2023 was JP Morgan Chase, an estimated $532M sold.
Based on aggregated 13F filings for Q1 2023.